Drug interaction profile of TKI alectinib allows effective and safe treatment of ALK+ lung cancer in the kidney transplant recipient

• Authors: BÍLEK Ondřej; HOLÁNEK Miloš; JUŘICA Jan; ŠTĚPÁNKOVÁ Soňa; VAŠINA Jiří; SELINGEROVÁ Iveta; POPRACH Alexandr; BOŘILOVÁ Simona; KAZDA Tomáš; KISS Igor; ZDRAŽILOVÁ DUBSKÁ Lenka
• Year of publication: 2021
• Type: Article in Periodical
• Magazine / Source: International Immunopharmacology
• Web: https://www.sciencedirect.com/science/article/pii/S1567576921006482
• Doi: http://dx.doi.org/10.1016/j.intimp.2021.108012